Home

Morning son Refreshing biogen aducanumab press release shame ball Elaborate

U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as  'big day" for patients | Reuters
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients | Reuters

Biogen releases long-term Aduhelm data
Biogen releases long-term Aduhelm data

Aduhelm (aducanumab) Q+A - Penn Memory Center
Aduhelm (aducanumab) Q+A - Penn Memory Center

Biogen's Aducanumab: A Look at the Drug's History and Recent Updates |  BioSpace
Biogen's Aducanumab: A Look at the Drug's History and Recent Updates | BioSpace

Aducanumab: will Biogen's Aduhelm recover from its rocky start? -  Pharmaceutical Technology
Aducanumab: will Biogen's Aduhelm recover from its rocky start? - Pharmaceutical Technology

Press Releases – Page 2 – Global Alzheimer's Platform Foundation
Press Releases – Page 2 – Global Alzheimer's Platform Foundation

After disastrous start to launch, Biogen still expects 'minimal' sales from  Aduhelm this year | Fierce Pharma
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year | Fierce Pharma

FDA approves Aduhelm, first new drug for Alzheimer's in 20 years, despite  questions - CBS News
FDA approves Aduhelm, first new drug for Alzheimer's in 20 years, despite questions - CBS News

Biogen gives up seeking European approval for aducanumab - Drug Discovery  and Development
Biogen gives up seeking European approval for aducanumab - Drug Discovery and Development

FDA Approval of a New Alzheimer's Drug Comes With Controversy | Smart News|  Smithsonian Magazine
FDA Approval of a New Alzheimer's Drug Comes With Controversy | Smart News| Smithsonian Magazine

James Deardorff on X: ""Biogen Plans Regulatory Filing for Aducanumab in  Alzheimer's Disease" - Hmm... 1. https://t.co/k7Ga4ja0br 2.  https://t.co/5cr8gYW72s https://t.co/7NboyUVjWr" / X
James Deardorff on X: ""Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease" - Hmm... 1. https://t.co/k7Ga4ja0br 2. https://t.co/5cr8gYW72s https://t.co/7NboyUVjWr" / X

Biogen's Alzheimer's drug approved by FDA, first new therapy in nearly two  decades
Biogen's Alzheimer's drug approved by FDA, first new therapy in nearly two decades

Aducanumab: New Medication FDA Approved for Alzheimer's Disease –  Psychiatry Education Forum
Aducanumab: New Medication FDA Approved for Alzheimer's Disease – Psychiatry Education Forum

Biogen Reverses Take on Aducanumab Trial Data | MedPage Today
Biogen Reverses Take on Aducanumab Trial Data | MedPage Today

Early Access Programs | Biogen
Early Access Programs | Biogen

FDA's Approval of Biogen's New Alzheimer's Drug Has Huge Cost Implications  for Medicare and Beneficiaries | KFF
FDA's Approval of Biogen's New Alzheimer's Drug Has Huge Cost Implications for Medicare and Beneficiaries | KFF

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease | Nature

Biogen readies Alzheimer's hopeful aducanumab for U.S. launch as stateside  sales plummet | Fierce Pharma
Biogen readies Alzheimer's hopeful aducanumab for U.S. launch as stateside sales plummet | Fierce Pharma

Aduhelm (aducanumab) Q+A - Penn Memory Center
Aduhelm (aducanumab) Q+A - Penn Memory Center

Medicare Finalizes Limits on Aducanumab Coverage | MedPage Today
Medicare Finalizes Limits on Aducanumab Coverage | MedPage Today

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based  on New Analysis of Larger Dataset from Phase 3 Studies | Biogen
Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on New Analysis of Larger Dataset from Phase 3 Studies | Biogen

With Spotlight on Alzheimer's Disease and Biogen, Competitors' Stocks Soar  | BioSpace
With Spotlight on Alzheimer's Disease and Biogen, Competitors' Stocks Soar | BioSpace

Biogen is ready to roll on lecanemab production, CFO says
Biogen is ready to roll on lecanemab production, CFO says

Congressional Probe of Alzheimer's Drug Approval Finds Fault With FDA  Actions | MedPage Today
Congressional Probe of Alzheimer's Drug Approval Finds Fault With FDA Actions | MedPage Today

June 7, 2021: A Historic Day | The Long and Winding Road...
June 7, 2021: A Historic Day | The Long and Winding Road...